FAQ

Complement C4d:EntNum:Pt:RBC:Qn

Known as: Complement C4d:Entitic Number:Point in time:Erythrocytes:Quantitative, fracción C4d del complemento:entítico:punto en el tiempo:eritrocitos:ordinal o cuantitativo:, Complément C4d:Nombre entitique:Temps ponctuel:GR:Quantitatif 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2017
0246820022017

Related topics

Related topics

3 relations
Complement System ProteinsErythrocytescomplement C4d

Related mentions per year

Related mentions per year

1936-2019
19401960198020002020
Complement C4d:EntNum:Pt:RBC:Qn
Erythrocytes
Complement System Proteins
complement C4d

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Glomerular C4d deposits can mark structural capillary wall remodelling in thrombotic microangiopathy and transplant glomerulopathy: C4d beyond active antibody-mediated injury: a retrospective study.
Peritubular capillary C4d (ptc-C4d) usually marks active antibody-mediated rejection, while pseudolinear glomerular capillary C4d… (More)
Is this relevant?
2015
2015
C4d as a Diagnostic Tool in Proliferative GN.
Proliferative GN is classified as immune complex-mediated or complement-mediated (C3 glomerulopathy). Immune complex-mediated GN… (More)
Is this relevant?
2015
2015
C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.
Antibody-mediated rejection (AMR) occurs in 10-20% of patients after heart transplantation. C4d immunostaining is one parameter… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
Is this relevant?
2013
2013
Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodies.
BACKGROUND Efforts to increase the specificity and sensitivity of human leukocyte antigen (HLA) antibody detection assays… (More)
Is this relevant?
2011
2011
Renal allograft pathology with C4d immunostaining in patients with graft dysfunction
Renal allograft biopsy is the gold standard for diagnosis of rejection. Incorporation of C4d as a marker for humoral rejection is… (More)
Is this relevant?
2010
2010
C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejection.
BACKGROUND Recent studies indicate that not all low-level donor-specific human leukocyte antigen (HLA) antibodies (HLA-DSA) (i.e… (More)
Is this relevant?
2008
2008
The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
BACKGROUND Renal biopsy is the gold standard for diagnosis of acute rejection in renal transplant recipients. The Banff (1997… (More)
Is this relevant?
2007
2007
C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status.
AIMS To determine whether C4d immunopositivity helps recognition of humoral rejection in dysfunctional liver allografts… (More)
Is this relevant?
2003
2003
Solid-state 13C and 1H spin diffusion NMR analyses of the microfibril structure for bacterial cellulose.
To obtain further information about the cause for the rather large splitting of the C4 resonance line into the downfield (C4D… (More)
Is this relevant?
2002
2002
Complement activated C4d immunoreactive oligodendrocytes delineate small cortical plaques in multiple sclerosis.
C4d-immunoreactive complement-activated oligodendrocytes (C4d-CAOs) have been described in several neurodegenerative diseases but… (More)
Is this relevant?